Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

Isolation and characterization of eight microsatellite loci in the brook lamprey Lampetra planeri (Petromyzontiformes) using 454 sequence data.

Schedina IM, Pfautsch S, Hartmann S, Dolgener N, Polgar A, Bianco PG, Tiedemann R, Ketmaier V.

J Fish Biol. 2014 Sep;85(3):960-4. doi: 10.1111/jfb.12470. Epub 2014 Jul 25.

PMID:
25059996
2.

Peripheral CD4+ cell prevalence and pleuropulmonary manifestations in systemic lupus erythematosus patients.

Vincze K, Kovats Z, Cseh A, Pasti K, Kiss E, Polgar A, Vasarhelyi B, Szabo AJ, Bohacs A, Tamasi L, Losonczy G, Müller V.

Respir Med. 2014 May;108(5):766-74. doi: 10.1016/j.rmed.2014.02.006. Epub 2014 Feb 18.

PMID:
24613209
3.

[Formulation of multiparticular drug delivery systems by compressing pellets into tablets].

Csobán Z, Kállai N, Polgár A, Antal I.

Acta Pharm Hung. 2013;83(4):134-42. Hungarian.

PMID:
24575659
4.

Outcomes of adult orthotopic heart transplantation with extended allograft ischemic time.

Yeen W, Polgar A, Guglin M, Downes K, Faber C, Roy A, Caldeira C.

Transplant Proc. 2013 Jul-Aug;45(6):2399-405. doi: 10.1016/j.transproceed.2013.04.003.

PMID:
23953555
5.

Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.

György B, Szabó TG, Turiák L, Wright M, Herczeg P, Lédeczi Z, Kittel A, Polgár A, Tóth K, Dérfalvi B, Zelenák G, Böröcz I, Carr B, Nagy G, Vékey K, Gay S, Falus A, Buzás EI.

PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.

6.

Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.

Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A.

Int Immunol. 2013 Jan;25(1):25-33. doi: 10.1093/intimm/dxs090. Epub 2012 Sep 7.

7.

Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters.

György B, Módos K, Pállinger E, Pálóczi K, Pásztói M, Misják P, Deli MA, Sipos A, Szalai A, Voszka I, Polgár A, Tóth K, Csete M, Nagy G, Gay S, Falus A, Kittel A, Buzás EI.

Blood. 2011 Jan 27;117(4):e39-48. doi: 10.1182/blood-2010-09-307595. Epub 2010 Nov 1.

8.

Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases.

Polgár A, Rózsa C, Müller V, Matolcsi J, Poór G, Kiss EV.

Autoimmun Rev. 2011 Jan;10(3):171-4. doi: 10.1016/j.autrev.2010.09.021. Epub 2010 Oct 12.

PMID:
20920613
9.

Cost-of-illness of patients with systemic sclerosis in a tertiary care centre.

Minier T, Péntek M, Brodszky V, Ecseki A, Kárpáti K, Polgár A, Czirják L, Gulácsi L.

Rheumatology (Oxford). 2010 Oct;49(10):1920-8. doi: 10.1093/rheumatology/keq165. Epub 2010 Jun 21.

10.

Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.

Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, Horváth G, Koó E, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L.

Scand J Rheumatol. 2010 Aug;39(4):303-9. doi: 10.3109/03009740903468982.

PMID:
20166848
11.

Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment.

Brodszky V, Bálint P, Géher P, Hodinka L, Horváth G, Koó É, Péntek M, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L.

Rheumatol Int. 2009 Dec;30(2):199-205. doi: 10.1007/s00296-009-0936-1.

PMID:
19381635
12.

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis.

György B, Tóthfalusi L, Nagy G, Pásztói M, Géher P, Lörinc Z, Polgár A, Rojkovich B, Ujfalussy I, Poór G, Pócza P, Wiener Z, Misják P, Koncz A, Falus A, Buzás EI.

Arthritis Res Ther. 2008;10(5):R110. doi: 10.1186/ar2507. Epub 2008 Sep 12.

13.

[Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary].

Péntek M, Szekanecz Z, Czirják L, Poór G, Rojkovich B, Polgár A, Genti G, Kiss CG, Sándor Z, Májer I, Brodszky V, Gulácsi L.

Orv Hetil. 2008 Apr 20;149(16):733-41. doi: 10.1556/OH.2008.28294. Hungarian.

PMID:
18426720
14.

Costs of rheumatoid arthritis in Hungary.

Péntek M, Kobelt G, Czirják L, Szekanecz Z, Poór G, Rojkovich B, Polgár A, Genti G, Kiss CG, Brodszky V, Májer I, Gulácsi L.

J Rheumatol. 2007 Jun;34(6):1437. No abstract available.

PMID:
17552071
15.

Interaction between nutrient supplies and aphid numbers on potato (2001-2002).

Polgár A, Kuroli G.

Commun Agric Appl Biol Sci. 2003;68(4 Pt A):255-63.

PMID:
15149116
16.

Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion.

Ortutay Z, Polgár A, Gömör B, Géher P, Lakatos T, Glant TT, Gay RE, Gay S, Pállinger E, Farkas C, Farkas E, Tóthfalusi L, Kocsis K, Falus A, Buzás EI.

Arthritis Rheum. 2003 Aug;48(8):2163-72.

17.

Individual number change of Empoasca spp. cicadas species in potato.

Polgár A, Kuroli G, Orosz A.

Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet. 2002;67(3):547-56.

PMID:
12696421
18.

Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases.

Polgár A, Falus A, Koó E, Ujfalussy I, Seszták M, Szuts I, Konrád K, Hodinka L, Bene E, Mészáros G, Ortutay Z, Farkas E, Paksy A, Buzás EI.

Rheumatology (Oxford). 2003 Apr;42(4):522-7.

19.
20.

Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells.

Holub MC, Hegyesi H, Igaz P, Polgár A, Toth S, Falus A.

Immunol Lett. 2002 Jun 3;82(1-2):79-84.

PMID:
12008038
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk